首页 正文

Predictive value of circulating microRNA-21 levels in patients with advanced non-small cell lung cancer treated with immunotherapy

{{output}}
Background: Pembrolizumab has been widely used to curb the disease progression of non-small-cell lung cancer (NSCLC), but 20% of patients treated with pembrolizumab have disease progression. MicroRNA-21 (miRNA-21) was highly expr... ...